Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer-Reference-Cited by-同舟云学术

Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer

Published:2015-08 Issue:2 Volume:68 Page:186-193
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Castro Elena,Goh Chee,Leongamornlert Daniel,Saunders Ed,Tymrakiewicz Malgorzata,Dadaev Tokhir,Govindasami Koveela,Guy Michelle,Ellis Steve,Frost Debra,Bancroft Elizabeth,Cole Trevor,Tischkowitz Marc,Kennedy M. John,Eason Jacqueline,Brewer Carole,Evans D. Gareth,Davidson Rosemarie,Eccles Diana,Porteous Mary E.,Douglas Fiona,Adlard Julian,Donaldson Alan,Antoniou Antonis C.,Kote-Jarai Zsofia,Easton Douglas F.,Olmos David,Eeles Rosalind

Publisher

Elsevier BV

Subject

Urology

Reference23 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Critical review of prostate cancer predictive tools;Shariat;Future Oncol,2009

3. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients;Kote-Jarai;Br J Cancer,2011

4. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer;Castro;J Clin Oncol,2013

5. Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy;Byrski;J Clin Oncol,2010

Cited by 296 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes;European Urology Open Science;2024-11

2. Prognostic value of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC);Urologic Oncology: Seminars and Original Investigations;2024-10

3. Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race;ClinicoEconomics and Outcomes Research;2024-09

4. Cancer de prostate métastatique résistant à la castration et inhibiteurs de PARP : de la génomique tumorale aux nouvelles associations thérapeutiques;Bulletin du Cancer;2024-09

5. Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement;Oncology in Clinical Practice;2024-08-21